New PET CT scanner at Bon Secours Hospital Limerick to improve patient access
Alliance Medical and Bon Secours Hospital Limerick are introducing the first PET CT scanner in the Mid-West region, set to reduce patient journeys to Dublin or Cork. The new service, part of the Clinical Services Hub, will offer advanced imaging technology for early detection of cancer, cardiac disease, and neurological conditions.

Via Live 95 Picture Library
Patients in the Mid-West will no longer have to travel to Dublin or Cork. Alliance Medical, in partnership with Bon Secours Hospital Limerick, has announced the introduction of the first PET CT scanner in the Mid-West region. The PET CT service will form a central part of Bon Secours Hospital Limerick's new Clinical Services Hub, located beside its new hospital in Ballysimon, and is scheduled to become fully operational in October 2025.
Once live, the PET service will provide patients across the Mid-West and beyond with timely access to advanced imaging technology that enables earlier and more accurate detection of cancer, cardiac disease, and neurological conditions.
\"We are proud to bring the first PET CT service to the Mid-West, working closely with Bon Secours Hospital Limerick to deliver this significant enhancement to patient care,\" said Malcolm Banks, Managing Director, Alliance Medical Ireland. \"As a company headquartered in Limerick for 25 years, this is an investment in the Mid-West. This partnership reflects our shared commitment to ensuring patients have rapid access to world-class diagnostic services, delivered locally and in a fully integrated clinical setting. Early diagnosis is key to successful treatment, and the Clinical Services Hub will ensure patients benefit from faster access and more coordinated care.\"
The new PET CT service is expected to significantly reduce patient waiting and travel times, meaning individuals in the Mid-West will no longer have to undertake journeys to Dublin or Cork for this vital scan. This local accessibility will also reduce waiting times, enhance early detection capabilities, and provide referring clinicians with highly detailed diagnostic information to guide treatment planning.
What's Your Reaction?






